跳至主要内容
临床试验/KCT0006526
KCT0006526已完成未知

Optimizing the dose of intrathecal morphine in patients undergoing laparoscopic donor hepatectomy; a randomized non-inferiority trial

Samsung Medical Center0 个研究点目标入组 56 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 60(Year)(—)
性别
All

入选标准

  • Patients who undergo living donor hepatectomy for liver transplantation
  • ASA physical status I or II

排除标准

  • ASA physical status III or more
  • Severe impaired coagulation profile (equal or more than INR 1.5 last coagulation test before the surgery)
  • Patients who have unstable coronary disease or Congestive heart failure or Arrhythmia or cardiomyopathy
  • Patients who have cerebrovascular disease
  • Patients who have systemic infection or local infection on lumbar
  • Chronic pain patients
  • Patients who don't understand about study or refuse the study
  • Patients who have history of severe psychological disease

研究者

相似试验

Optimizing the dose of intrathecal morphine in... | 临床试验